Delivery Order SPE2DX22D0010-SPE2D825FHS89
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $10,330.72 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, is a non-set-aside competitive award. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX)...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,543.55 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The work...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at approximately $28,946 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 11, 2025, with completion targeted for August 12, 2025. This firm fixed price delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The delivery order was competitively awarded with no...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,662.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order was competitively awarded with...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,173.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 20, 2025, with an ultimate completion date of August 21, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion vehicle running through December 2026 that serves as the company's primary vehicle...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,246.70 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $31,367.68 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2.93 million to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,045.04 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 7, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the company's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $529,408.33 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHS89Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $30,745.14 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 18, 2025, with a completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of pharmaceutical products and medical supplies to federal military and veteran healthcare systems through its DLA contracts. The company's portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. This delivery order is part of the broader Pharmaceutical Prime Vendor Global Program that the DLA intends to expand with multiple regional awards involving multiple contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.7k | 8/18/25 |